La Rochelle
La Rochelle
La Rochelle, Charente-Maritime, France3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2026-09-25 | NCT06717347 | |
| Outcome of Patients With Severe Mental Illness in the Intensive Care Unit | Frailty, Mental Disorders, Severe, Pathologic Processes, Pathological Conditions, Signs and Symptoms, psychiatric disorder | Not yet recruiting | Not stated | 2026-07-16 | NCT07705802 | |
| Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study | Metastatic Non-squamous Lung Cancer | Recruiting | Phase 3 | 2025-06-25 | NCT05692999 |